jim cramer on eli lilly's covid-19 phase 2 trial results for antibody drug
Published 3 years ago • 8.8K plays • Length 4:27Download video MP4
Download video MP3
Similar videos
-
5:32
lilly tests covid-19 antibody drug in nursing home facilities
-
1:15
eli lilly starts late-stage trial for covid-19 antibody drug in nursing homes
-
9:22
eli lilly ceo discusses its coronavirus antibody drug and the latest on its breast cancer treatment
-
4:10
jim cramer: eli lilly pausing antibody trial isn't a big setback
-
3:48
eli lilly’s chief scientific officer on covid antibody drug results
-
2:53
cathie wood defends early sale of nvidia shares: tiger money
-
3:37
cramer’s stop trading: lululemon
-
4:49
mcghee: every portfolio should include defensive stocks, not just growth
-
1:54
coronavirus: eli lilly launches first human trial of a new type of treatment
-
0:41
jim cramer on the huge potential for eli lilly's answer to ozempic #shorts
-
2:44
jim cramer on how eli lilly could be impacted by mixed alzheimer's drug study results
-
5:19
watch cnbc's interview with eli lilly's chief scientific officer on the new covid-19 antibody drug
-
3:07
jim cramer: i remain very positive on eli lilly as the drug stock of the year
-
3:32
jim cramer on how lilly's alzheimer's drug compares to biogen's
-
4:21
eli lilly cfo on q2 earnings and coronavirus treatment
-
2:55
eli lilly's experimental obesity drug could be 'revolutionary,' says jim cramer
-
5:00
eli lilly pausing covid-19 trials is not a big deal: jefferies managing director
-
2:39
eli lilly antibody drug reduces covid-19 risk in nursing homes: study
-
1:05
eli lilly files for emergency use authorization of its covid-19 antibody drug
-
2:02
jim cramer explains why eli lilly will be the winner over biogen in alzheimer's fight
-
3:13
eli lilly ceo: we see a path to an alzheimer's disease-modifying drug
-
2:49
jim cramer explains why he favors eli lilly in the weight loss drug space